{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "cancer",
      "immunotherapy",
      "interleukin 17 (IL-17)",
      "tumor microenvironment"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "27589729",
  "DateCompleted": {
    "Year": "2017",
    "Month": "03",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2016",
        "Month": "08",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "1433",
      "10.3390/ijms17091433"
    ],
    "Journal": {
      "ISSN": "1422-0067",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "9",
        "PubDate": {
          "Year": "2016",
          "Month": "Aug",
          "Day": "30"
        }
      },
      "Title": "International journal of molecular sciences",
      "ISOAbbreviation": "Int J Mol Sci"
    },
    "ArticleTitle": "Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.",
    "Abstract": {
      "AbstractText": [
        "The inflammatory process contributes to immune tolerance as well as to tumor progression and metastasis. By releasing extracellular signals, cancerous cells constantly shape their surrounding microenvironment through their interactions with infiltrating immune cells, stromal cells and components of extracellular matrix. Recently, the pro-inflammatory interleukin 17 (IL-17)-producing T helper lymphocytes, the Th17 cells, and the IL-17/IL-17 receptor (IL-17R) axis gained special attention. The IL-17 family comprises at least six members, IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (also called IL-25), and IL-17F. Secreted as disulfide-linked homo- or heterodimers, the IL-17 bind to the IL-17R, a type I cell surface receptor, of which there are five variants, IL-17RA to IL-17RE. This review focuses on the current advances identifying the promoting role of IL-17 in carcinogenesis, tumor metastasis and resistance to chemotherapy of diverse solid cancers. While underscoring the IL-17/IL-17R axis as promising immunotherapeutic target in the context of cancer managing, this knowledge calls upon further in vitro and in vivo studies that would allow the development and implementation of novel strategies to combat tumors."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut Jean Godinot, Unicancer, 1 rue du G\u00e9n\u00e9ral Koenig, F-51726 Reims, France. fabrejoseph@yahoo.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Reims-Champagne-Ardenne, DERM-I-C, EA7319, 51 rue Cognacq-Jay, F-51095 Reims, France. fabrejoseph@yahoo.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "Centre Hospitalo-Universitaire Henri Mondor, Service de Radioth\u00e9rapie, 51 Avenue du Mar\u00e9chal de Lattre de Tassigny, F-94010 Cr\u00e9teil, France. fabrejoseph@yahoo.fr."
          }
        ],
        "LastName": "Fabre",
        "ForeName": "Joseph",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut Jean Godinot, Unicancer, 1 rue du G\u00e9n\u00e9ral Koenig, F-51726 Reims, France. jerome.giustiniani@gmail.com."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Reims-Champagne-Ardenne, DERM-I-C, EA7319, 51 rue Cognacq-Jay, F-51095 Reims, France. jerome.giustiniani@gmail.com."
          }
        ],
        "LastName": "Giustiniani",
        "ForeName": "Jerome",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut Jean Godinot, Unicancer, 1 rue du G\u00e9n\u00e9ral Koenig, F-51726 Reims, France. Christian.GARBAR@reims.unicancer.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Reims-Champagne-Ardenne, DERM-I-C, EA7319, 51 rue Cognacq-Jay, F-51095 Reims, France. Christian.GARBAR@reims.unicancer.fr."
          }
        ],
        "LastName": "Garbar",
        "ForeName": "Christian",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Reims-Champagne-Ardenne, DERM-I-C, EA7319, 51 rue Cognacq-Jay, F-51095 Reims, France. frank.antonicelli@univ-reims.fr."
          }
        ],
        "LastName": "Antonicelli",
        "ForeName": "Frank",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut Jean Godinot, Unicancer, 1 rue du G\u00e9n\u00e9ral Koenig, F-51726 Reims, France. yacine.merrouche@reims.unicancer.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Reims-Champagne-Ardenne, DERM-I-C, EA7319, 51 rue Cognacq-Jay, F-51095 Reims, France. yacine.merrouche@reims.unicancer.fr."
          }
        ],
        "LastName": "Merrouche",
        "ForeName": "Yacine",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U976, H\u00f4pital Saint Louis, F-75010 Paris, France. armand.bensussan@inserm.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Laboratoire Immunologie Dermatologie & Oncologie, UMR-S 976, F-75475 Paris, France. armand.bensussan@inserm.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "OREGA Biotech, 69130 Ecully, France. armand.bensussan@inserm.fr."
          }
        ],
        "LastName": "Bensussan",
        "ForeName": "Armand",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U976, H\u00f4pital Saint Louis, F-75010 Paris, France. martine.bagot@aphp.fr."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Laboratoire Immunologie Dermatologie & Oncologie, UMR-S 976, F-75475 Paris, France. martine.bagot@aphp.fr."
          }
        ],
        "LastName": "Bagot",
        "ForeName": "Martine",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, Laboratoire Immunologie Dermatologie & Oncologie, UMR-S 976, F-75475 Paris, France. reem.al-daccak@inserm.fr."
          }
        ],
        "LastName": "Al-Dacak",
        "ForeName": "Reem",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Int J Mol Sci",
    "NlmUniqueID": "101092791",
    "ISSNLinking": "1422-0067"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-17"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Immunotherapy"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Interleukin-17"
    },
    {
      "QualifierName": [
        "classification",
        "immunology",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "T-Lymphocytes, Helper-Inducer"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Tumor Microenvironment"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}